New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease

Overview

Journal Front Pharmacol

Date 2022 Feb 17

PMID 35173618

Authors

Jing Xu

Hao-Ming Xu

Mei-Feng Yang

Yu-Jie Liang

Quan-Zhou Peng

Yuan Zhang

Cheng-Mei Tian

Li-Sheng Wang

Jun Yao

Yu-Qiang Nie

De-Feng Li

Affiliations

Soon will be listed here.

Abstract

Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the colonic mucosa. Environmental factors, genetics, intestinal microbiota, and the immune system are all involved in the pathophysiology of IBD. Lately, accumulating evidence has shown that abnormal epigenetic changes in DNA methylation, histone markers, and non-coding RNA expression greatly contribute to the development of the entire disease. Epigenetics regulates many functions, such as maintaining the homeostasis of the intestinal epithelium and regulating the immune system of the immune cells. In the present study, we systematically summarized the latest advances in epigenetic modification of IBD and how epigenetics reveals new mechanisms of IBD. Our present review provided new insights into the pathophysiology of IBD. Moreover, exploring the patterns of DNA methylation and histone modification through epigenetics can not only be used as biomarkers of IBD but also as a new target for therapeutic intervention in IBD patients.

Citing Articles

Histone deacetylase in inflammatory bowel disease: novel insights.

Li C, Gu S, Zhang Y, Zhang Z, Wang J, Gao T Therap Adv Gastroenterol. 2025; 18:17562848251318833.

PMID: 39963253 PMC: 11831641. DOI: 10.1177/17562848251318833.

Eleven Grand Challenges for Inflammatory Bowel Disease Genetics and Genomics.

Gibson G, Rioux J, Cho J, Haritunians T, Thoutam A, Abreu M Inflamm Bowel Dis. 2024; 31(1):272-284.

PMID: 39700476 PMC: 11700891. DOI: 10.1093/ibd/izae269.

Epithelial NSD2 maintains FMO-mediated taurine biosynthesis to prevent intestinal barrier disruption.

Xu Y, Xiao X, Ma C, Wang Z, Feng W, Rao H Clin Transl Med. 2024; 14(12):e70128.

PMID: 39658533 PMC: 11835373. DOI: 10.1002/ctm2.70128.

From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies.

Gharib E, Robichaud G Int J Mol Sci. 2024; 25(17).

PMID: 39273409 PMC: 11395697. DOI: 10.3390/ijms25179463.

Restore Intestinal Barrier Integrity: An Approach for Inflammatory Bowel Disease Therapy.

Kong C, Yang M, Yue N, Zhang Y, Tian C, Wei D J Inflamm Res. 2024; 17:5389-5413.

PMID: 39161679 PMC: 11330754. DOI: 10.2147/JIR.S470520.

References

White C, Pone E, Lam T, Tat C, Hayama K, Li G . Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses. J Immunol. 2014; 193(12):5933-50. PMC: 4258531. DOI: 10.4049/jimmunol.1401702. View

Goodrich J, Waters J, Poole A, Sutter J, Koren O, Blekhman R . Human genetics shape the gut microbiome. Cell. 2014; 159(4):789-99. PMC: 4255478. DOI: 10.1016/j.cell.2014.09.053. View

Cutler D, Zwick M, Okou D, Prahalad S, Walters T, Guthery S . Dissecting Allele Architecture of Early Onset IBD Using High-Density Genotyping. PLoS One. 2015; 10(6):e0128074. PMC: 4476779. DOI: 10.1371/journal.pone.0128074. View

He C, Yu T, Shi Y, Ma C, Yang W, Fang L . MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1. Gastroenterology. 2017; 152(6):1434-1448.e15. DOI: 10.1053/j.gastro.2017.01.049. View

Wei M, Gao X, Liu L, Li Z, Wan Z, Dong Y . Visceral Adipose Tissue Derived Exosomes Exacerbate Colitis Severity Pro-inflammatory MiRNAs in High Fat Diet Fed Mice. ACS Nano. 2020; 14(4):5099-5110. DOI: 10.1021/acsnano.0c01860. View

Brandtzaeg P . Update on mucosal immunoglobulin A in gastrointestinal disease. Curr Opin Gastroenterol. 2010; 26(6):554-63. DOI: 10.1097/MOG.0b013e32833dccf8. View

Brandtzaeg P, Carlsen H, Halstensen T . The B-cell system in inflammatory bowel disease. Adv Exp Med Biol. 2006; 579:149-67. DOI: 10.1007/0-387-33778-4_10. View

Jostins L, Ripke S, Weersma R, Duerr R, McGovern D, Hui K . Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012; 491(7422):119-24. PMC: 3491803. DOI: 10.1038/nature11582. View

Perconti G, Rubino P, Contino F, Bivona S, Bertolazzi G, Tumminello M . RIP-Chip analysis supports different roles for AGO2 and GW182 proteins in recruiting and processing microRNA targets. BMC Bioinformatics. 2019; 20(Suppl 4):120. PMC: 6471694. DOI: 10.1186/s12859-019-2683-y. View

10.

Gonsky R, Deem R, Landers C, Derkowski C, Berel D, McGovern D . Distinct IFNG methylation in a subset of ulcerative colitis patients based on reactivity to microbial antigens. Inflamm Bowel Dis. 2010; 17(1):171-8. PMC: 3400263. DOI: 10.1002/ibd.21352. View

11.

Wu F, Guo N, Tian H, Marohn M, Gearhart S, Bayless T . Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 2010; 17(1):241-50. PMC: 2998576. DOI: 10.1002/ibd.21450. View

12.

de Zoeten E, Wang L, Sai H, Dillmann W, Hancock W . Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. Gastroenterology. 2009; 138(2):583-94. PMC: 3369426. DOI: 10.1053/j.gastro.2009.10.037. View

13.

Pan W, Sommer F, Falk-Paulsen M, Ulas T, Best L, Fazio A . Exposure to the gut microbiota drives distinct methylome and transcriptome changes in intestinal epithelial cells during postnatal development. Genome Med. 2018; 10(1):27. PMC: 5899322. DOI: 10.1186/s13073-018-0534-5. View

14.

Xu M, Zuo D, Liu X, Fan H, Chen Q, Deng S . MiR-155 contributes to Th17 cells differentiation in dextran sulfate sodium (DSS)-induced colitis mice via Jarid2. Biochem Biophys Res Commun. 2017; 488(1):6-14. DOI: 10.1016/j.bbrc.2017.04.143. View

15.

Garrido-Mesa J, Rodriguez-Nogales A, Algieri F, Vezza T, Hidalgo-Garcia L, Garrido-Barros M . Immunomodulatory tetracyclines shape the intestinal inflammatory response inducing mucosal healing and resolution. Br J Pharmacol. 2018; 175(23):4353-4370. PMC: 6240124. DOI: 10.1111/bph.14494. View

16.

Neudecker V, Haneklaus M, Jensen O, Khailova L, Masterson J, Tye H . Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. J Exp Med. 2017; 214(6):1737-1752. PMC: 5460990. DOI: 10.1084/jem.20160462. View

17.

Trevino L, Dong J, Kaushal A, Katz T, Jangid R, Robertson M . Epigenome environment interactions accelerate epigenomic aging and unlock metabolically restricted epigenetic reprogramming in adulthood. Nat Commun. 2020; 11(1):2316. PMC: 7210260. DOI: 10.1038/s41467-020-15847-z. View

18.

Wang H, Chao K, Ng S, Bai A, Yu Q, Yu J . Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease. Genome Biol. 2016; 17:58. PMC: 4815271. DOI: 10.1186/s13059-016-0901-8. View

19.

McDermott E, Ryan E, Tosetto M, Gibson D, Burrage J, Keegan D . DNA Methylation Profiling in Inflammatory Bowel Disease Provides New Insights into Disease Pathogenesis. J Crohns Colitis. 2015; 10(1):77-86. PMC: 5013897. DOI: 10.1093/ecco-jcc/jjv176. View

20.

Richards E . Inherited epigenetic variation--revisiting soft inheritance. Nat Rev Genet. 2006; 7(5):395-401. DOI: 10.1038/nrg1834. View